Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

In an effort to better serve our users, we have streamlined our content offering. As a result, we no longer publish new content or update existing content in Renal Cell Carcinoma. Visit the 'Content & Subscriptions' tab of your Settings page at any time to update your Dashboard or Newsletter Subscription preferences to continue to see news and information that interests you most.

Published in Renal Cell Carcinoma

Journal Scan / Research · September 09, 2021

Model Development: Prognostic Factors for Overall Survival in Patients With Clear Cell Metastatic RCC

Medicine (Baltimore)

 

Additional Info

Disclosure statements are available on the authors' profiles:

Medicine (Baltimore)
Prognostic Factors for Overall Survival in Patients With Clear Cell Metastatic Renal Cell Carcinoma: Model Development and External Validation With Memorial Sloan Kettering Cancer Center Model and the International Metastatic Renal Cell Carcinoma Database Consortium Model
Medicine (Baltimore) 2021 Aug 06;100(31)e26826, D Shin, CW Jeong, C Song, M Kang, SI Seo, JK Kim, H Lee, J Chung, SH Hong, EC Hwang, C Kwak, JY Park

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading